Top 3 Health Care Stocks That May Implode In Q1

As of Feb. 2, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.

Here's the latest list of major overbought players in this sector.

Brookdale Senior Living Inc (NYSE:BKD)

• On Jan. 28, Brookdale Senior Living reported FY25 preliminary revenue of $3.2 billion. “We are pleased with the progress we made in 2025 and are very excited about the opportunity we have over the next several years to further drive value for shareholders in light of the very favorable industry supply and demand dynamics and our focus on operational excellence,” said Nick Stengle, Brookdale’s Chief Executive Officer. The company's stock gained around 39% over the past month and has a 52-week high of $15.06.
• RSI Value: 89.1                                
• BKD Price Action: Shares of Brookdale Senior Living gained 3.5% to close at $15.00 on Friday.
• Edge Stock Ratings: 97.10 Momentum score.

Mirum Pharmaceuticals Inc (NASDAQ:MIRM)

• On Jan. 30, Morgan Stanley analyst Michael Ulz maintained Mirum Pharmaceuticals with an Overweight rating and raised the price target from $95 to $123. The company's stock gained around 31% over the past month and has a 52-week high of $103.81.
• RSI Value: 80.8
• MIRM Price Action: Shares of Mirum Pharmaceuticals rose 0.3% to close at $103.22 on Friday.

Amicus Therapeutics, Inc. (NASDAQ:FOLD)

• On Dec. 19, Amicus Therapeutics announced it will be acquired by BioMarin. The company's stock gained around 139% over the past six months and has a 52-week high of $14.38.
• RSI Value: 80.4
• FOLD Price Action: Shares of Amicus Therapeutics gained 0.1% to close at $14.29 on Friday.

Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.

Photo via Shutterstock